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Abstract
We report four cases who were referred to Mansoura University Teaching Hospital, Egypt
suffering from abdominal pain and gastrointestinal manifestations. The patients' history was
unremarkable, except that they had contact with dogs and live in rural communities. Laboratory
findings showed peripheral blood eosinophilia, leucocytosis, and elevated liver enzymes. Serological
tests were positive in three cases. Ultrasonography showed well-circumscribed cystic masses in the
liver. Diagnosis of hydatid cysts was confirmed by computed tomography (CT). Surgical treatment
along with chemotherapy was performed and all patients recovered well. The results of these cases
support the notion that CT scan can led to increased clarity, regarding surgical management,
because of discordance between radiographic and laboratory findings.
Background
Human cystic echinococcosis (CE)/hydatidosis is a dog-
borne zoonoses caused by infection with the larval stage
of the dwarf tapeworm of the genus Echinococcus. E. gran-
ulosus and E. multilocularis are the most important mem-
bers of the genus in respect of their public health
importance and their geographical distribution [1]. The
life cycle of Echinococcus is indirect and involves two hosts,
one definitive carnivore host and the other intermediate
herbivore host [2]. The problem arises when humans act
as an accidental intermediate host and ingest viable onco-
sphere-containing eggs, which have been shed in the fae-
ces of the definitive host. The oncospheres invade the
intestines, enter the vasculature and develop into hydatid
cysts in any organ or tissue, where a variety of symptoms
can be produced. However, the liver acts as the first filter
for hydatid larvae, making it the most commonly affected
organ followed by lung [1].
The diagnosis of CE is based on the patient's history, clin-
ical findings, haematological and serum biochemical pro-
files, and serological testing, which may be negative in
10% to 20% of cases [3]. Efforts to improve diagnostic
accuracy have led to integration of a range of imaging
techniques into the diagnostic armamentarium [1,4]. The
radical surgical removal of the cystic lesion remains the
mainstay of treatment with a high success rate [1,4].
Chemotherapy, with benzimidazole compounds has also
been used with some success to sterilize the cyst, decrease
the chance of anaphylaxis, and reduce the complications
and recurrence rate post-operatively. In recent years, a
third treatment option was introduced (PAIR, puncture,
aspiration, injection, and re-aspiration) and is indicated
for patients who cannot undergo surgery [5,6].
Despite efforts to control CE in many parts of the world
the disease continues to exert a heavy burden on human
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health. And, in a number of countries, including Egypt,
CE is re-emerging as a major public health issue, with
potentially life-threatening complications [7]. Herein, we
report four cases of CE from Egypt.
Case presentation
The four patients described in this report were seen and
evaluated in the Department of Internal Tropical Medi-
cine, Mansoura University Teaching Hospital, Egypt
between January 1, 2007 and September 30, 2007 for
complaints of abdominal pain and gastrointestinal (GI)
manifestations. Patients were interviewed and examined
by a physician, after which venous blood samples were
drawn from an antecubital vein and were processed
immediately. Blood samples were assessed for some hae-
matological parameters, including red blood cell count
(RBC), white blood cell count (WBC), eosinophil (%)
and hemoglobin (Hb) content. Analysis was done using
an Automated Hematological Analyzer, Sysmex TM-K-
1000 (TOA Medical Electronics Company Ltd., Kobe,
Japan). Sera were used to determine some key biochemi-
cal parameters. These included: (1) total serum bilirubin
using commercial kit (Quimica Clinica Aplicada, Spain),
and (2) activity levels of alanine aminotransferase/aspar-
tate aminotransferase (ALT/AST) and alkaline phos-
phatase (ALKP), markers of hepatocellular damage
according to Reitman-Frankel colorimetric transaminase
procedure.
The serum samples were tested by the echinococcosis hae-
magglutination test (IHA) Fumouze®  (Laboratoires
Fumouze, Levallois-Perret, France) and ELISA (F-Form,
Maxisorp, Nunc, Roskilde, Denemark). Pre-operative
diagnosis of hepatic cystic lesions was made ultrasonically
and confirmed by a computer tomography (CT) scan.
After completion of this evaluation process surgical con-
sultation was sought. All four patients were successfully
managed surgically and all were asymptomatic at the two
years follow-up (Table 1). This research was approved by
the Mansoura University Faculty of Medicine Ethics
Board.
A provisional diagnosis of hydatid disease was made
based on the clinical manifestations, haematological and
biochemical parameters, and serological tests. The diag-
nosis was confirmed by radiological imaging. The impor-
tant demographics and clinical features, laboratory
findings and therapeutic intervention in these patients are
summarised in table 1. The mean age of the patients was
28.3 (range 11–43) years. Of the four patients, three were
male and one was female. Three of the four cases had fre-
quent contact with dogs and farm animals and live in agri-
cultural sheep-grazing area which is in line with the
Table 1: Pertinent details of hepatic hydatid cases.
Case 1 Case 2 Case 3 Case 4
Gender Female Male Male Male
Age (Years) 22 11 37 43
Occupation Student Farmer Farmer Shepherd
Residence Suburban Rural Rural Rural
Dog contact No Yes Yes Yes
Symptoms Abdominal pain, nausea Indigestion, easy fatigability Generalized abdominal pain, 
nausea, vomiting, diarrhoea
Pain in right 
hypochondrium, nausea, 
vomiting, weight loss
Physical examination Hepatomegaly Normal Normal Hepatomegaly
Hemoglobin (g/dl) 12 13.2 14 14.1
RBCs (106/ml) 3.9 4.4 4.8 4.5
WBCs (103/ml) 8.4 12.7 6.6 19.2
Eosinophils (%) 8 18 4 17
Bilirubin (mg/dl) 1.7 2.2 0.9 1.2
ALT (U/ml) 58 34 22 41
AST (U/ml) 74 61 34 36
ALKP (U/L) 18 22 16 11
Serology (test)
IHA Positive Negative Positive Positive
ELISA Positive Negative Positive Positive
Maximal diameter (cm) 6 14 5 6
Cyst type III I I I
Concurrent locations Spleen -- -- --
Surgical Treatment Complete pericystectomy Complete pericystectomy Complete pericystectomy Complete pericystectomy
Postoperative 
complications
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general epidemiology of hydatidosis. All patients were
non-alcoholic and non-smoker. Presenting signs and
symptoms for the 4 patients are listed in Table 1. All of
them had intermittent colicky pain associated with nausea
and vomiting. Except one patient (case one) who has a
history of acute symptoms lasting 1–2 months, their mild
symptoms began more than one year ago.
Haematological studies revealed leucocytosis in all cases
and eosinophilia in three cases. RBC count and Hb con-
tent were within normal range. Total serum bilirubin was
elevated in three cases and was within normal range in
one case (case three). The biochemical serum level of ALT
was significantly raised in one patient (case one) and the
AST level was increased in cases one and two. Analysis of
the liver enzyme ALKP revealed abnormal increase in
three cases and normal level in case four. Serologic echi-
nococcal tests are valuable when they are positive, but one
of the four hepatic hydatidosis cases gives a false negative.
Although serology tests like ELISA and IHA can help make
the diagnosis, complete reliance on them is not recom-
mended.
Radiographic evaluation confirmed the variable nature of
the clinical hydatid disease that has been previously
reported [8]. Hepatic radiograph appearance was variable
and revealed abnormal findings (Fig. 1). In case one (Fig.
1A) liver had a relatively large size, normal echopattern,
but, with two well defined sonolucent cysts with thin
internal septae. Liver in case two (Fig. 1B) showed average
size with a well defined hypodense non-enhancing
hydatid cystic lesion and is seen affecting segment V and
VI. It also compressed the gall bladder, displaced the pat-
ent non-dilated portal vein (PV). No other focal lesions
and no dilatation of the intra or extra-hepatic bile ducts
were noticed. Liver in case three (Fig. 1C) had a large well-
defined hypodense hydatid cyst involving the postro-
superior segment of the right lobe (segment VII). The liver
Photographs of transverse computed tomography scan through the liver showing cystic hydatid lesions Figure 1
Photographs of transverse computed tomography scan through the liver showing cystic hydatid lesions. Figs. A, 
B, C, and D refer to case one to four, respectively. Arrows indicate the hydatid cyst.Cases Journal 2009, 2:58 http://www.casesjournal.com/content/2/1/58
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of case four (Fig. 1D) was enlarged with smooth contour
and uniform enhancing parenchyma with normal patent
PV. Multiple variable-sized cystic lesions are seen scattered
in both hepatic lobes. Further investigations ruled out
coexistent hydatid disease in other organs except spleen in
case one.
Discussion
From a clinical point of view, clinical manifestations of
hydatidosis in humans are variable, most patients seem to
tolerate the infection for extended periods without any
symptomatology, or they may suddenly show dramatic
and acute symptoms [8]. All four patients made an excel-
lent recovery following surgical excision of the entire
cystic masses. Adjunctive Albendazole chemotherapy 10
mg/kg/day was prescribed for 4–6 weeks before surgery to
sterilise the cyst and for 2 months post-operatively to
reduce the recurrence rate. At the 24-month follow-up
after surgery, the patient remained free of symptoms and
continued to do well. This result is consistent with other
studies that found that CT scan has become an extremely
useful and valuable diagnostic tool in the management of
patients with hydatidosis [1,9]. Accuracy would have been
enhanced by concomitant magnetic resonance imaging
(MRI). But, MRI was not performed in this study, though
we recognise that these might have been helpful [10].
As frequently as it occurs, hydatidosis can sometimes be a
diagnostic quandary. With the concern that, left
untreated, even solitary hydatid cyst in critical organ(s)
will likely progress to grave and life-threatening illness,
surgeons have historically coped with diagnostic uncer-
tainty by accepting high negative surgical intervention
rates as an alternative to risking disease progression.
Taken haematological, biochemical, serological and
imaging findings into account, some recommendations
for more accurate and sensitive detection of clinical cases,
regarding surgical management, can be made: (1) diagno-
sis is best accomplished by a combination of imaging,
serologic, and laboratory investigations; (2) radiographic
examination must be considered for patients in whom
hydatidosis is a potential diagnosis; and (3) patients with
equivocal history, physical findings, or laboratory results
should not be considered negative unless there are no
obvious positive radiographic findings.
Despite major advances in our understanding and treat-
ment of hydatidosis over the past two decades, control of
this zoonotic disease remains a challenging endeavour.
Fortunately, because of the high risk of infection, the high
morbidity rate and the unpredictable outcome of hydatid
infection, there is an increasing realization in interna-
tional health agencies that hydatidosis is an important
disease that causes life-threatening morbidity. Like many
diseases, prevention is the key to control, and we know
that simple changes in social habits and hygiene can pre-
vent infection and disease in humans. Also, chemoproph-
ylaxis is an effective measure to protect humans living in
endemic or hyperendemic areas of hydatid infection.
In conclusion, we stress the importance of maintaining a
high level of clinical awareness that hepatic hydatidosis
continues to be a clinical problem especially in endemic
regions of the world and travellers to these areas should be
made aware of the need to take on extra-measures to avoid
hydatid disease. In endemic areas like Egypt any cystic
enlargement of soft tissue should raise the suspicion of cli-
nicians of hydatid disease. Serologic tests, ultrasonogra-
phy, and CT should be performed before any invasive
procedure.
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